AIGH Capital Management LLC
AIGH Capital Management LLC reported 89 holdings worth US$1.59B as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 7, 2026
AIGH Capital Management LLC reported 89 holdings worth US$1.59B as of Jun 30, 2026. Largest: Sandisk Corporation, Maxlinear, Inc and Intel Corporation. Filed Aug 7, 2026 (Form 13F).
- Holdings
- 89
- Value as reported
- US$1.59B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Sandisk Corporation | 149K | US$339M | 21.4% |
| Maxlinear, Inc | 818K | US$105M | 6.6% |
| Intel Corporation | 624K | US$87.1M | 5.5% |
| Digital Turbine, Inc. | 6.55M | US$84.5M | 5.3% |
| Clearfield, Inc. | 1.01M | US$40.1M | 2.5% |
| Methode Electronics, Inc. | 1.68M | US$31.8M | 2.0% |
| Amtech Systems, Inc. | 1.25M | US$28.9M | 1.8% |
| Fennec Pharmaceuticals Inc. | 2.49M | US$26.7M | 1.7% |
| Kyverna Therapeutics, Inc. | 2.8M | US$24.9M | 1.6% |
| Personalis, Inc. | 1.72M | US$23M | 1.4% |
| 3d Systems Corporation | 7.27M | US$22M | 1.4% |
| Vuzix Corporation | 6.75M | US$19.6M | 1.2% |
| Abeona Therapeutics Inc. | 2.99M | US$18.5M | 1.2% |
| Ardelyx, Inc. | 3.2M | US$16.3M | 1.0% |
| Biodesix, Inc. | 678K | US$15.3M | 0.96% |
| Spruce Biosciences, Inc. | 250K | US$13.5M | 0.85% |
| Castle Biosciences, Inc. | 545K | US$13M | 0.82% |
| Vanda Pharmaceuticals Inc. | 2.04M | US$12.5M | 0.79% |
| Pelthos Therapeutics Inc. | 329K | US$9.3M | 0.59% |
| Verastem, Inc. | 1.93M | US$7.36M | 0.46% |
| Broadwind, Inc. | 1.16M | US$5.58M | 0.35% |
| Aeye, Inc. | 3.85M | US$5.55M | 0.35% |
| Orthopediatrics Corp. | 270K | US$5.16M | 0.33% |
| Apyx Medical Corporation | 1.13M | US$5.07M | 0.32% |
| Ideal Power Inc. | 895K | US$4.8M | 0.30% |
| Talphera, Inc. | 4.6M | US$4.74M | 0.30% |
| Tigo Energy, Inc. | 1.99M | US$4.64M | 0.29% |
| Energous Corporation | 182K | US$4.38M | 0.28% |
| Renovorx, Inc. | 4.41M | US$4.32M | 0.27% |
| Richardson Electronics, Ltd. | 200K | US$3.81M | 0.24% |
| Neuraxis, Inc. | 520K | US$3.8M | 0.24% |
| Coya Therapeutics, Inc. | 632K | US$3.7M | 0.23% |
| Identiv, Inc. | 1.45M | US$3.65M | 0.23% |
| Elutia, Inc. | 2.7M | US$2.64M | 0.17% |
| Aprea Therapeutics, Inc. | 1.02M | US$815K | 0.05% |
| Biofrontera Inc. | 740K | US$700K | 0.04% |
| Nn, Inc. | 11,496 | US$41,271 | <0.01% |
| Protara Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Regal Rexnord Corporation | 0 | US$0 | 0.00% |
| Smartkem, Inc. | 0 | US$0 | 0.00% |
| Zebra Technologies Corporation | 0 | US$0 | 0.00% |
| Zevra Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Bk Technologies Corporation | 0 | US$0 | 0.00% |
| Esperion Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Generac Holdings Inc. | 0 | US$0 | 0.00% |
| Intellicheck, Inc. | 0 | US$0 | 0.00% |
| Larimar Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Lightpath Technologies, Inc. | 0 | US$0 | 0.00% |
| Lipocine Inc. | 0 | US$0 | 0.00% |
| Nlight, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related